Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Equine Pharmaceuticals and Supplements market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.
This report presents the market size and development trends by detailing the Equine Pharmaceuticals and Supplements market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Equine Pharmaceuticals and Supplements market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Equine Pharmaceuticals and Supplements industry and will help you to build a panoramic view of the industrial development.
Equine Pharmaceuticals and Supplements Market, By Type:
Pharmaceuticals
Supplements
Equine Pharmaceuticals and Supplements Market, By Application:
Veterinary Hospitals
Drug Stores
Others
Some of the leading players are as follows:
Merial
Elanco Animal Health
Vetoquinol
Affymetrix
Novartis Animal Health
Celltrion Inc
Zoetis
Boehringer Ingelheim
Merck Animal Health
Bayer Animal Health
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Equine Pharmaceuticals and Supplements Market: Technology Type Analysis
-
4.1 Equine Pharmaceuticals and Supplements Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Equine Pharmaceuticals and Supplements Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Pharmaceuticals
4.3.2 Supplements
5 Equine Pharmaceuticals and Supplements Market: Product Analysis
-
5.1 Equine Pharmaceuticals and Supplements Product Market Share Analysis, 2018 & 2026
-
5.2 Equine Pharmaceuticals and Supplements Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Equine Pharmaceuticals and Supplements Market: Application Analysis
-
6.1 Equine Pharmaceuticals and Supplements Application Market Share Analysis, 2018 & 2026
-
6.2 Equine Pharmaceuticals and Supplements Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Veterinary Hospitals
6.3.2 Drug Stores
6.3.3 Others
7 Equine Pharmaceuticals and Supplements Market: Regional Analysis
-
7.1 Equine Pharmaceuticals and Supplements Regional Market Share Analysis, 2018 & 2026
-
7.2 Equine Pharmaceuticals and Supplements Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Merial
9.1.1 Merial Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Elanco Animal Health
9.2.1 Elanco Animal Health Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Vetoquinol
9.3.1 Vetoquinol Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Affymetrix
9.4.1 Affymetrix Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Novartis Animal Health
9.5.1 Novartis Animal Health Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Celltrion Inc
9.6.1 Celltrion Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Zoetis
9.7.1 Zoetis Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck Animal Health
9.9.1 Merck Animal Health Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bayer Animal Health
9.10.1 Bayer Animal Health Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 66 Figures and 126 Tables)
Figure Pharmaceuticals Equine Pharmaceuticals and Supplements market, 2015 - 2026 (USD Million)
Figure Supplements Equine Pharmaceuticals and Supplements market, 2015 - 2026 (USD Million)
Figure Veterinary Hospitals market, 2015 - 2026 (USD Million)
Figure Drug Stores market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)
-
Table North America Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table North America Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table North America Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Canada Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Canada Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Europe Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)
-
Table Europe Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Europe Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Europe Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Germany Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Germany Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table France Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table France Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Italy Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Italy Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Spain Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Spain Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table China Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table China Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Japan Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Japan Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table India Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table India Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table MEA Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)
-
Table MEA Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table MEA Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table MEA Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Merial Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Elanco Animal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vetoquinol Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Affymetrix Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Animal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celltrion Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zoetis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Animal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Animal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
